Concepedia

Michael R. Leadbetter

MR

Statistics

Publications

13

Citations

1K

H-Index

13

Active since

1968

Affiliations

Ardelyx (United States)(Current)

Yale University

Theravance Biopharma (United States)

Michael R. Leadbetter is an author at Ardelyx (United States) specializing in pharmacology, medicinal chemistry, and gastrointestinal pharmacology.

Publications per year

1968–2022

13

Publications

13

Development and Characterization of a Human and Mouse Intestinal Epithelial Cell Monolayer Platform

Kenji Kozuka, Ying He, Samantha Koo-McCoy et al. · Stem Cell Reports · 2017 · 181 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424)

Michael R. Leadbetter, Stacy M. Adams, BETTINA BAZZINI et al. · The Journal of Antibiotics · 2004 · 164 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Intestinal Inhibition of the Na <sup>+</sup> /H <sup>+</sup> Exchanger 3 Prevents Cardiorenal Damage in Rats and Inhibits Na <sup>+</sup> Uptake in Humans

Andrew Spencer, Eric D. Labonté, David P. Rosenbaum et al. · Science Translational Medicine · 2014 · 152 citations

Medicine, Nephrology, Physiology +13

Nonradioactive nucleic acid detection by enhanced chemiluminescence using probes directly labeled with horseradish peroxidase

Denise Pollard-Knight, Christopher A. Read, M. J. Downes et al. · Analytical Biochemistry · 1990 · 111 citations

Life Sciences, Chemistry, Molecular Biology +12

Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD

Eric D. Labonté, Christopher W. Carreras, Michael R. Leadbetter et al. · Journal of the American Society of Nephrology · 2014 · 107 citations · Full text

Medicine, Nutrition, Pharmacology +17

1–5 of 13